Mechanisms of Mast Cell Activation in Severe Asthma: Beyond IgE
Peter Bradding
DOI: https://doi.org/10.1164/rccm.202110-2322ED
IF: 24.7
2022-02-16
American Journal of Respiratory and Critical Care Medicine
Abstract:Mast cells (MCs) are present in all heathy human tissues and exhibit marked heterogeneity with respect to their development, mediator content, ultrastructure, and function (1). They secrete a vast arsenal of biological substances including the classical autacoid mediators (histamine, prostaglandin D 2 , and leukotriene C 4 ), proteases, and cytokines. They respond rapidly to a multitude of perceived tissue insults with the initiation of a coordinated program of inflammation and repair. Potentially beneficial MC roles include protection against infection (2), kidney injury (3), envenomation (4), and in some circumstances, cancer progression (5). However, when a tissue insult is repeated or continuous, the effects of MC mediators are potentially deleterious, and it is not surprising that MCs are implicated in the pathophysiology of many diverse diseases including asthma (1) and idiopathic pulmonary fibrosis (6).
What problem does this paper attempt to address?